Keros Therapeutics
KROS
#8811
Rank
ยฃ0.15 B
Marketcap
ยฃ7.89
Share price
-0.38%
Change (1 day)
-22.59%
Change (1 year)

Revenue for Keros Therapeutics (KROS)

Revenue in 2026 (TTM): ยฃ24.4 Million

According to Keros Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ24.78 Million. In 2025 the company made a revenue of ยฃ0.18 Billion an increase over the revenue in the year 2024 that were of ยฃ2.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Keros Therapeutics from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) ยฃ24.4 M-86.53%
2025 ยฃ0.18 B6306.27%
2024 ยฃ2.82 M2286.76%
2023 ยฃ0.11 M
2022 N/A-100%
2021 ยฃ14.89 M
2020 N/A-100%
2019 ยฃ7.62 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA